pharmatracks limited
pharmatracks limited Company Information
Company Number
06991814
Website
www.pharmatracks.comRegistered Address
eagle house 25 severn street, welshpool, powys, SY21 7AD
Industry
Other personal service activities n.e.c.
Telephone
-
Next Accounts Due
May 2025
Group Structure
View All
Directors
Helen Usmar15 Years
Shareholders
ms helen marie usmar 100%
pharmatracks limited Estimated Valuation
Pomanda estimates the enterprise value of PHARMATRACKS LIMITED at £54.1k based on a Turnover of £83.1k and 0.65x industry multiple (adjusted for size and gross margin).
pharmatracks limited Estimated Valuation
Pomanda estimates the enterprise value of PHARMATRACKS LIMITED at £0 based on an EBITDA of £-17.1k and a 4.24x industry multiple (adjusted for size and gross margin).
pharmatracks limited Estimated Valuation
Pomanda estimates the enterprise value of PHARMATRACKS LIMITED at £0 based on Net Assets of £-42.4k and 2.03x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Pharmatracks Limited Overview
Pharmatracks Limited is a live company located in powys, SY21 7AD with a Companies House number of 06991814. It operates in the other service activities n.e.c. sector, SIC Code 96090. Founded in August 2009, it's largest shareholder is ms helen marie usmar with a 100% stake. Pharmatracks Limited is a established, micro sized company, Pomanda has estimated its turnover at £83.1k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Pharmatracks Limited Health Check
Pomanda's financial health check has awarded Pharmatracks Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 5 areas for improvement. Company Health Check FAQs
0 Strong
4 Regular
5 Weak
Size
annual sales of £83.1k, make it smaller than the average company (£854.1k)
- Pharmatracks Limited
£854.1k - Industry AVG
Growth
3 year (CAGR) sales growth of 5%, show it is growing at a similar rate (6.1%)
- Pharmatracks Limited
6.1% - Industry AVG
Production
with a gross margin of 41.5%, this company has a comparable cost of product (41.5%)
- Pharmatracks Limited
41.5% - Industry AVG
Profitability
an operating margin of -20.6% make it less profitable than the average company (6.2%)
- Pharmatracks Limited
6.2% - Industry AVG
Employees
with 1 employees, this is below the industry average (14)
1 - Pharmatracks Limited
14 - Industry AVG
Pay Structure
on an average salary of £30k, the company has an equivalent pay structure (£30k)
- Pharmatracks Limited
£30k - Industry AVG
Efficiency
resulting in sales per employee of £83.1k, this is equally as efficient (£83.1k)
- Pharmatracks Limited
£83.1k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Pharmatracks Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Pharmatracks Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Pharmatracks Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (48 weeks)
0 weeks - Pharmatracks Limited
48 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 34814.8%, this is a higher level of debt than the average (43.8%)
34814.8% - Pharmatracks Limited
43.8% - Industry AVG
PHARMATRACKS LIMITED financials
Pharmatracks Limited's latest turnover from August 2023 is estimated at £83.1 thousand and the company has net assets of -£42.4 thousand. According to their latest financial statements, Pharmatracks Limited has 1 employee and maintains cash reserves of £122 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Aug 2023 | Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||||||||
| Other Income Or Grants | ||||||||||||||
| Cost Of Sales | ||||||||||||||
| Gross Profit | ||||||||||||||
| Admin Expenses | ||||||||||||||
| Operating Profit | ||||||||||||||
| Interest Payable | ||||||||||||||
| Interest Receivable | ||||||||||||||
| Pre-Tax Profit | ||||||||||||||
| Tax | ||||||||||||||
| Profit After Tax | ||||||||||||||
| Dividends Paid | ||||||||||||||
| Retained Profit | ||||||||||||||
| Employee Costs | ||||||||||||||
| Number Of Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Aug 2023 | Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 122 | 244 | 377 | 1,682 | 2,169 | 604 | 536 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 122 | 244 | 377 | 1,682 | 2,169 | 604 | 536 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 21,829 | 19,800 | 0 | 16,954 | 32,059 | 56,002 | 50,305 | 24,292 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 2,784 | 7,523 | 26,107 | 0 | 0 | 1,925 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 122 | 36 | 200 | 142 | 8,139 | 155,698 | 13,608 | 312 | 74 | 9,748 | 23,553 | 10,953 | 45,408 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 122 | 36 | 2,984 | 7,665 | 34,246 | 177,527 | 33,408 | 2,237 | 17,028 | 41,807 | 79,555 | 61,258 | 69,700 | 0 |
| total assets | 122 | 36 | 2,984 | 7,665 | 34,246 | 177,527 | 33,408 | 2,359 | 17,272 | 42,184 | 81,237 | 63,427 | 70,304 | 536 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23,591 | 32,099 | 55,414 | 40,242 | 42,066 | 1,643 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 42,474 | 25,248 | 13,228 | 4,300 | 1,800 | 0 | 32,407 | 19,314 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 42,474 | 25,248 | 13,228 | 4,300 | 1,800 | 61,785 | 32,407 | 19,314 | 23,591 | 32,099 | 55,414 | 40,242 | 42,066 | 1,643 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 42,474 | 25,248 | 13,228 | 4,300 | 1,800 | 61,785 | 32,407 | 19,314 | 23,591 | 32,099 | 55,414 | 40,242 | 42,066 | 1,643 |
| net assets | -42,352 | -25,212 | -10,244 | 3,365 | 32,446 | 115,742 | 1,001 | -16,955 | -6,319 | 10,085 | 25,823 | 23,185 | 28,238 | -1,107 |
| total shareholders funds | -42,352 | -25,212 | -10,244 | 3,365 | 32,446 | 115,742 | 1,001 | -16,955 | -6,319 | 10,085 | 25,823 | 23,185 | 28,238 | -1,107 |
| Aug 2023 | Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | Aug 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | ||||||||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 122 | 122 | 499 | 1,305 | 1,507 | 1,362 | 332 | 264 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Tax | ||||||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 0 | -2,784 | -4,739 | -18,584 | 4,278 | 2,029 | 17,875 | -15,029 | -15,105 | -23,943 | 5,697 | 26,013 | 24,292 | 0 |
| Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -23,591 | -8,508 | -23,315 | 15,172 | -1,824 | 40,423 | 1,643 |
| Accruals and Deferred Income | 17,226 | 12,020 | 8,928 | 2,500 | 1,800 | -32,407 | 13,093 | 19,314 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||||||||
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | ||||||||||||||
| cash flow from financing | ||||||||||||||
| cash and cash equivalents | ||||||||||||||
| cash | 86 | -164 | 58 | -7,997 | -147,559 | 142,090 | 13,296 | 238 | -9,674 | -13,805 | 12,600 | -34,455 | 45,408 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 86 | -164 | 58 | -7,997 | -147,559 | 142,090 | 13,296 | 238 | -9,674 | -13,805 | 12,600 | -34,455 | 45,408 | 0 |
pharmatracks limited Credit Report and Business Information
Pharmatracks Limited Competitor Analysis
Perform a competitor analysis for pharmatracks limited by selecting its closest rivals, whether from the OTHER SERVICE ACTIVITIES sector, other micro companies, companies in SY21 area or any other competitors across 12 key performance metrics.
pharmatracks limited Ownership
PHARMATRACKS LIMITED group structure
Pharmatracks Limited has no subsidiary companies.
Ultimate parent company
PHARMATRACKS LIMITED
06991814
pharmatracks limited directors
Pharmatracks Limited currently has 1 director, Ms Helen Usmar serving since Aug 2009.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Ms Helen Usmar | Wales | 47 years | Aug 2009 | - | Director |
P&L
August 2023turnover
83.1k
+7%
operating profit
-17.1k
0%
gross margin
41.6%
+3.57%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
August 2023net assets
-42.4k
+0.68%
total assets
122
+2.39%
cash
122
+2.39%
net assets
Total assets minus all liabilities
pharmatracks limited company details
company number
06991814
Type
Private limited with Share Capital
industry
96090 - Other personal service activities n.e.c.
incorporation date
August 2009
age
15
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
August 2023
previous names
N/A
accountant
-
auditor
-
address
eagle house 25 severn street, welshpool, powys, SY21 7AD
Bank
-
Legal Advisor
-
pharmatracks limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to pharmatracks limited.
pharmatracks limited Companies House Filings - See Documents
| date | description | view/download |
|---|
